https://ca.prisysbiotech.com/ No - Human Primat Investigació Plataforma & CRO | PRISYS Biotecnologia https://ca.prisysbiotech.com/uploads/39406/logo.png https://ca.prisysbiotech.com/safety-evaluation/ Avaluació de seguretat https://ca.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://ca.prisysbiotech.com/nhp-pharmacology/ Farmacologia NHP https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://ca.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://ca.prisysbiotech.com/translation-research/ Recerca en traducció https://ca.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://ca.prisysbiotech.com/biosafety-research/ Recerca en Bioseguretat https://ca.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://ca.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://ca.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://ca.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://ca.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://ca.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://ca.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ca.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://ca.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://ca.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://ca.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://ca.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://ca.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://ca.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://ca.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://ca.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://ca.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://ca.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://ca.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://ca.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://ca.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://ca.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://ca.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://ca.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://ca.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://ca.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://ca.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://ca.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://ca.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://ca.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://ca.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://ca.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://ca.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://ca.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://ca.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://ca.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://ca.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://ca.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://ca.prisysbiotech.com/pk-pd-adme/adme.html ADME https://ca.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://ca.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://ca.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://ca.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://ca.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://ca.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://ca.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://ca.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://ca.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://ca.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://ca.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://ca.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://ca.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://ca.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://ca.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://ca.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://ca.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://ca.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://ca.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://ca.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://ca.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://ca.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://ca.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://ca.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://ca.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://ca.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://ca.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://ca.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://ca.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://ca.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://ca.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://ca.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://ca.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://ca.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://ca.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://ca.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://ca.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://ca.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://ca.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://ca.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://ca.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://ca.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://ca.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://ca.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://ca.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://ca.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://ca.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://ca.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://ca.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://ca.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://ca.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://ca.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://ca.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://ca.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://ca.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://ca.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://ca.prisysbiotech.com/translation-research/clinical-imaging.html Imatge Clínica https://ca.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Imatge Clínica https://ca.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://ca.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://ca.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://ca.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://ca.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://ca.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://ca.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://ca.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://ca.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://ca.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://ca.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://ca.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://ca.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://ca.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://ca.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://ca.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://ca.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://ca.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://ca.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://ca.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://ca.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://ca.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Model de diabetis mellitus tipus 2 https://ca.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Model de diabetis mellitus tipus 2 https://ca.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://ca.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://ca.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://ca.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://ca.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://ca.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://ca.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://ca.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://ca.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://ca.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://ca.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://ca.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://ca.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://ca.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://ca.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://ca.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://ca.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://ca.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://ca.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://ca.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://ca.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://ca.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://ca.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://ca.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://ca.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://ca.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://ca.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://ca.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://ca.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://ca.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://ca.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://ca.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://ca.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://ca.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://ca.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://ca.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://ca.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://ca.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://ca.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://ca.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://ca.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://ca.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://ca.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://ca.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://ca.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://ca.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://ca.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://ca.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://ca.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://ca.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://ca.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://ca.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://ca.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://ca.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://ca.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://ca.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://ca.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003293807076352.html Imatge molecular en models de NHP per al desenvolupament de fàrmacs translacionals https://ca.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://ca.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17970373556642816.html Seminari web NHP BehaviorAtles|Seguiment del comportament NHP 3D per al desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://ca.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724115743302656.html Recapitulació de 2025: com Prisys està redefinint la fiabilitat translacional a la recerca de NHP https://ca.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://ca.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17563486407697408.html NHP - Farmacologia i serveis farmacodinàmics basats|PRISYS Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ca.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17532427722712064.html Conegueu Prisys Biotech a la propera Roadshow de la UE: setembre de 2025 https://ca.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://ca.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17457947871454208.html Prisys Biotech-2025 Revisió de mig any https://ca.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ca.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243636640261120.html Conegueu Prisys al proper US-Roadshow el març del 2025 https://ca.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ca.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83993443.html Informe anual PRISYS 2024: avançar en models de NHP i investigació preclínica https://ca.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://ca.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-78082053.html Butlletí Prisys Biotech 2024 Q2: R+D preclínica millorada per a terapèutiques del SNC amb models de reacció creuada PRISYS https://ca.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://ca.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028084761420800.html Per què els models animals tenen èxit o fracàs en el desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021155917194240.html Participació quantitativa de PET objectiu en NHP per a fàrmacs del SNC https://ca.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://ca.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015460359513088.html Del vídeo a les dades: seguiment 3D d'IA per al comportament del NHP https://ca.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://ca.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015554473845760.html Imatge de biodistribució de PET en primats no-humans https://ca.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://ca.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003293697090560.html PBPK vs. Models compartimentals: per què importa PBPK https://ca.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://ca.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993353522865152.html Recapitulació del seminari web: avançar en la investigació translacional de NHP mitjançant el fenotipat conductual digital https://ca.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://ca.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990481380975616.html Biomarcadors PK en el desenvolupament preclínic de fàrmacs|Exposició–Resposta i PK/PD https://ca.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://ca.prisysbiotech.com/news/behavior-in-rhesus-17986803414656000.html Comportament espontani-autolesiu en macacs Rhesus: un model de NHP translacional per al desenvolupament de fàrmacs neuropsiquiàtrics https://ca.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://ca.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17986803504800768.html Models d'eficàcia MIDD i NHP en el desenvolupament de fàrmacs translacionals https://ca.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://ca.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17978550016500736.html AI-Anàlisi del comportament NHP 3D impulsada|Fenotipat conductual sense marcadors https://ca.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://ca.prisysbiotech.com/news/webinar-nhp-behavioratlas-17978550013862912.html Webinar global|Quantificació de comportaments complexos de NHP: introducció de l'Atles de comportament de NHP per al fenotipat conductual en 3D d'alta{0}}fidelitat https://ca.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://ca.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17970373552137216.html AI-Anàlisi del comportament de NHP per al desenvolupament preclínic de fàrmacs|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://ca.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17978550589596672.html Quan introduir estudis de NHP en el desenvolupament de fàrmacs autoimmunes https://ca.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://ca.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17978550462358528.html Models NHP IBD: què ens ensenya l'enterocolitis crònica als macacs Rhesus sobre la inflamació intestinal translacional https://ca.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://ca.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17978550130287616.html Lliurament d'AAV guiat per ressonància magnètica-en models cerebrals NHP per a la teràpia gènica del SNC https://ca.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://ca.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17978550097142784.html Per què són importants els fàrmacs de control positiu en els models de malalties autoimmunes|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://ca.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17978550036276224.html Detecció inicial de l'ADA en micos-rentats per a estudis biològics preclínics https://ca.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://ca.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17970373709554688.html Mecanismes del dolor: el model de cremades solars UVB és una eina de translació vital https://ca.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://ca.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17970373759804416.html Models NHP de programació de dieta materna alta-en greixos i obesitat infantil https://ca.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://ca.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17950620318082048.html Interpretació de la patologia clínica en gossos i primats no humans en estudis preclínics https://ca.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://ca.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17950620040619008.html Biomarcadors d'imatge molecular: avançar en la investigació translacional i el desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://ca.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17950620123505664.html Què és la farmacocinètica no lineal? Mecanismes, característiques i implicacions per al desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://ca.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17950620193268736.html Per què la imatge molecular de NHP és fonamental per als estudis de PET translacionals https://ca.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://ca.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17950620148933632.html Què és la imatge molecular i per què és important en el desenvolupament de fàrmacs? https://ca.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://ca.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17950620243731456.html Estudis de biodistribució de radionúclids de NHP: imatges moleculars per al desenvolupament de fàrmacs translacionals https://ca.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://ca.prisysbiotech.com/news/nhp-heart-failure-model-17950620000281600.html El model d'insuficiència cardíaca NHP dóna suport a la investigació translacional sobre la teràpia gènica de restauració de telòmers https://ca.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://ca.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17950620144247808.html Com les imatges DSA i CTA milloren l'avaluació de la seguretat dels fàrmacs cardiovasculars https://ca.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://ca.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17950620121080832.html Model de trombosi de derivació arteriovenosa del NHP en micos Cynomolgus per a l'avaluació de fàrmacs antitrombòtics translacionals https://ca.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://ca.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888513062626304.html Dades farmacocinètiques com a biomarcador translacional https://ca.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://ca.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888514071684096.html Models no-de primats humans de fibrosi pulmonar: avançar en la precisió translacional en el desenvolupament de fàrmacs respiratoris https://ca.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://ca.prisysbiotech.com/news/nhp-models-translational-drug-development-17888512921035776.html Per què el desenvolupament de fàrmacs depèn cada cop més dels models de NHP|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://ca.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888513343480832.html Dades de PK com a biomarcador farmacodinàmic: avançar en el desenvolupament de fàrmacs translacionals mitjançant la farmacologia quantitativa https://ca.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://ca.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17857871207474176.html Estudis de farmacologia no -GLP per a la presentació normativa: integritat de les dades i requisits de laboratori https://ca.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://ca.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17857857618551808.html Disseny estratègic d'estudis farmacocinètics no clínics: des de l'elaboració de perfils ADME fins a la presa de decisions translacionals- https://ca.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://ca.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17857857078633472.html NHP AV-Model de trombosi de derivació per a l'avaluació de la seguretat dels fàrmacs|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://ca.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17857845235295232.html Què és la farmacocinètica no lineal? Mecanismes i Avaluació Translacional PK|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://ca.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17857845236081664.html Prisys Biotech admet l'aprovació IND de UX-GIP001 per part de la FDA i el CDE|Plataforma de lliurament de NHP CNS https://img01.v15cdn.com/gallery/4x3/157.webp https://ca.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17857844710319104.html Seguiment de cèl·lules immunitàries in vivo i desenvolupament de traçadors PET en models de NHP|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://ca.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17857844721411072.html Imatges PET de transportador de dopamina en models NHP|Imatge del SNC|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://ca.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17857844242588672.html Biodistribució PET/TC en models de NHP per al lliurament de fàrmacs al SNC|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://ca.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17857844366550016.html Gran-Radioetiquetatge d'animals i plataforma d'imatge in vivo per al desenvolupament de fàrmacs translacionals https://ca.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://ca.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17857844429480960.html Per què el desenvolupament de fàrmacs es basa cada vegada més en models de NHP: el paper essencial dels primats en la medicina translacional|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://ca.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17857844296377344.html Reptes i solucions de desenvolupament de fàrmacs IPF|Models NHP amb TC i PFT https://ca.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://ca.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17857844173628416.html AI Markerless NHP 3D Behavior Analysis System per a la investigació preclínica https://ca.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://ca.prisysbiotech.com/news/evaluating-dmpk-properties-17857844485022720.html Avaluació de les propietats DMPK dels compostos candidats en el descobriment precoç de fàrmacs|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://ca.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17857844137862144.html Ressonància magnètica-Lliurament guiat del SNC en models de NHP|Plataforma translacional IMRI i CED https://ca.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://ca.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17857844709565440.html Estudis de biodistribució del NHP SNC|Lliurament intratecal d'ARN|PRISYS Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://ca.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17857844229841920.html Marc translacional PK/PD: predicció de la dosi del mico Cynomolgus a l'ésser humà|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://ca.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724115823453184.html Quan el dolor es converteix en un record: els impulsors emocionals del dolor crònic i l'avantatge del model NHP|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://ca.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724115708961792.html Avaluació del dolor multi-final: el futur del desenvolupament de fàrmacs analgèsics https://ca.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://ca.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724116461085696.html Per què fracassen tants analgèsics en assaigs preclínics? La resposta rau en com mesurem el dolor https://ca.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://ca.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724116068131840.html Disseny de punt temporal de mostreig de sang en estudis de farmacocinètica (PK)|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://ca.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724115902751744.html Estadístiques de PK: paràmetres d'anàlisi no-compartimental (NCA) i aplicacions preclíniques https://ca.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://ca.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724115710043136.html Per què els models de primats no-humans són crítics per a la terapèutica d'oligonucleòtids del SNC https://ca.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://ca.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724115708404736.html Metabolisme de l'àcid úric en humans vs micos: implicacions translacionals per al desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://ca.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724115645539328.html Model de fibrosi hepàtica associada a-primats no humans MASH-|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://ca.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724115655042048.html Per què l'IMRI-l'entrega guiada de fàrmacs per al cervell és essencial per a una orientació precisa en estudis de NHP https://ca.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://ca.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674166152127488.html Sistema d'anàlisi del comportament NHP 3D impulsat per AI-Markerless|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://ca.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674166083855360.html LPS-Model NHP de la inflamació pulmonar aguda induïda (ALI)|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://ca.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674166332662784.html HDM+SEB-Model de dermatitis atòpica induïda (AtD) en micos Cynomolgus https://ca.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://ca.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674166519718912.html Explicació dels models PK d'un- a multi-compartiment|Farmacocinètica NHP|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://ca.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674166410503168.html Com triar un CRO preclínic fiable|Criteris clau per a les empreses biotecnològiques|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://ca.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674165941101568.html Avaluació CAR-T translacional: experiència in vitro i suport a l'estudi de NHP — Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://ca.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674166251856896.html Per què més del 90% dels candidats a fàrmacs del SNC fracassen en els assaigs clínics? https://ca.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://ca.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674166642107392.html Models preclínics de la malaltia de Parkinson: una guia per seleccionar models de neurotoxines, genètics i NHP|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://ca.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674166061278208.html Lliurament de medicaments d'alta-precisió i plataformes de traducció de NHP impulsades- IA https://ca.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://ca.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17664203603698688.html Models d'immunologia NHP impulsats per Th17|Recerca autoimmune translacional a Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://ca.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17664203700085760.html Sistema BehaviorAtlas® basat en IA-NHP|Plataforma d'anàlisi del comportament 3D|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://ca.prisysbiotech.com/news/rfp-template-for-nhp-studies-17664203744125952.html Plantilla de RFP per a estudis de NHP|Accelerar l'eficiència de la investigació preclínica https://ca.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://ca.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17664203610956800.html Model de dolor d'al·lodínia freda en micos Cynomolgus|Prisys Biotechnologies https://ca.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://ca.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17664203667170304.html MRI-Plataforma de lliurament de fàrmacs intracerebrals guiats|Prisys Biotech CNS Research https://ca.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://ca.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17664203847148544.html Models de malalties respiratòries de NHP i plataforma de lliurament de fàrmacs per via aèria|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://ca.prisysbiotech.com/news/nhp-renal-biopsy-17664203862074368.html Plataforma de biòpsia renal de NHP i models de malaltia renal|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://ca.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17664209744847872.html Estudis PK i lliurament dirigit de medicaments|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://ca.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17664203678884864.html Plataforma d'anàlisi del comportament basada en -Investigació en NHP de Prisys Biotechnologies i IA https://ca.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://ca.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17664203559576576.html Tecnologia d'entrega nasal-al-cervell (N2B) per a la investigació del SNC|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://ca.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17664203544421376.html SHR-2004: un avenç en la prevenció de TEV per a pacients amb càncer d'ovari: una història d'èxit de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://ca.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17541900629337088.html Models de mico Cynomolgus i Rhesus|Prisys Biotech Preclínica CRO https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17532427470808064.html Fibrosi pulmonar idiopàtica (IPF) Model NHP|Prisys biotech preclinical cro https://ca.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://ca.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17532427469513728.html Estudis de biodistribució del mico Cynomolgus|Prisys Biotech Preclínica CRO https://ca.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://ca.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17532427589329920.html Prisys Biotech NHP Models per a la investigació d’hematologia i ictus https://ca.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://ca.prisysbiotech.com/news/the-importance-of-administration-volume-17532427398669312.html La importància del volum d’administració en estudis preclínics|PRISYS Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://ca.prisysbiotech.com/news/brain-targeted-drug-delivery-17532427406599168.html Brain - lliurament de medicaments dirigits|Investigació NHP preclínica de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://ca.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17532427447755776.html Desenvolupament de fàrmacs ADC|Marc translacional de PK/PD en estudis preclínics de NHP https://ca.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://ca.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17502552775910400.html Models de dolor de NHP per a descobriment de drogues translacionals|PRISYS Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://ca.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17502552750629888.html Sèrum vs. Plasma: elecció de la matriu òptima per a la bioanàlisi preclínica https://ca.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://ca.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17502552734852096.html Directrius de dosificació preclínica: volum IV i PO, PH i osmolaritat per a una PK precisa en NHP i altres espècies https://ca.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://ca.prisysbiotech.com/news/nhp-copd-model-17502553073214464.html Models de recerca més importants i excel·lència de la plataforma respiratòria per prisys https://ca.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://ca.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17502552613610496.html Model d’hemorràgia aguda de NHP: una eina crucial per accelerar una nova hematologia del desenvolupament de medicaments https://ca.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://ca.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17502552725939200.html Investigació de Pruritus: model NHP induït per IL-31 de Prisys Biotech per avaluar teràpies anti-picades https://ca.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://ca.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17457948064228352.html Una guia per a l'avaluació d'anticossos anti-droga (ADA). https://img01.v15cdn.com/gallery/4x3/148.webp https://ca.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17457948086363136.html Teràpies respiratòries: la plataforma integrada de NHP de Prisys Biotech per a la investigació preclínica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17457948170986496.html Models de dolor de NHP: acceleració del desenvolupament de medicaments analgèsics a Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://ca.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17457947811472384.html Plataformes del model NHP per donar suport al desenvolupament de medicaments en malalties complexes https://ca.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ca.prisysbiotech.com/news/key-considerations-for-dosing-volume-17457947900470272.html Consideracions clau per a la dosificació del volum, el pH i la formulació en models animals https://ca.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://ca.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17457947811013632.html Exosomes dissenyats: revolucionant el lliurament de fàrmacs per a trastorns del SNC: coneixements preclínics de Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://ca.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17457947742528512.html Principis rectors per a la selecció d'espècies animals en estudis de toxicologia de fàrmacs d'àcid nucleic https://img01.v15cdn.com/gallery/4x3/148.webp https://ca.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17457947831198720.html DSA i IMRI de Prisys Biotech per a estudis de malalties hematològiques, vasculars i renals https://ca.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://ca.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17457947768415232.html Models de dolor de mico Cynomolgus: impulsar la investigació translacional per a una terapèutica innovadora del canal iònic https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17457963589493760.html Advancing Atopic Dermatitis Research: Model de Prisys Biotech no humà (NHP) https://ca.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://ca.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17457947865228288.html Model de dermatitis Atòpica de NHP de Prisys Biotech per al desenvolupament de fàrmacs anti-prurítics https://ca.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://ca.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374217893864448.html Disseny d'estudis en animals: consideracions clau per a l'èxit de la investigació preclínica https://img01.v15cdn.com/gallery/4x3/300.webp https://ca.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374217677906944.html Dermatitis atòpica: com els models de mico de Cynomolgus avancen de precisió terapèutica https://ca.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://ca.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374217483281408.html Recerca sobre l'asma: per què els models de primats no-humans són fonamentals per al desenvolupament de nous fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374217486148608.html Comprendre la farmacocinètica dels oligonucleòtids antisentit (ASO): factors clau en l'absorció i la distribució https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374218250920960.html Estudis d'inhalació de NHP per a productes biològics: Serveis CRO preclínics especialitzats de PRISYS https://img01.v15cdn.com/gallery/4x3/300.webp https://ca.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374217460491264.html Estudis preclínics avançats d'inhalació: capacitats tècniques i experiència a Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://ca.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374217533727744.html Comprensió de la farmacocinètica (PK): paràmetres i aplicacions clau en el desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://ca.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374217679201280.html Injecció intracerebroventricular (ICV): lliurament de precisió del SNC per a la investigació preclínica https://ca.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://ca.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374217546163200.html Injecció intracerebral (ICM): orientació de precisió per a terapèutiques del SNC: consideracions preclíniques https://img01.v15cdn.com/gallery/4x3/148.webp https://ca.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374217520456704.html Injecció intratecal (IT): una via de lliurament directa del SNC per a teràpies avançades: consideracions preclíniques https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374217490932736.html Avançar la investigació de la malaltia de Parkinson amb el model NHP https://img01.v15cdn.com/gallery/4x3/300.webp https://ca.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374217766872064.html Estudis preclínics de PK/PD i models de NHP per al desenvolupament de fàrmacs|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://ca.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299040456041472.html Orientació a la interleucina-31 (IL-31): una nova frontera en el desenvolupament de fàrmacs per a malalties autoimmunes - Models de NHP de Prisys Biotech per a la investigació preclínica https://ca.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://ca.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295536708150272.html Avaluació de la immunotoxicitat no clínica: estratègia, consideracions clau i selecció del mètode https://img01.v15cdn.com/gallery/4x3/232.webp https://ca.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295498813547520.html Les proves microbianes i el seu impacte en els primats no-humans en estudis preclínics de DMPK https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295464179622912.html Model d’endometriosi mico de cynomolgus per avançar en la investigació terapèutica https://ca.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://ca.prisysbiotech.com/news/membranous-nephropathy-model-17295463939515392.html Desenvolupament de fàrmacs per a la nefropatia membranosa (MN) avançada: plataforma de models de mico Cynomolgus de Prisys Biotech https://img01.v15cdn.com/gallery/4x3/148.webp https://ca.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295464190239744.html Farmacocinètica dels fàrmacs inhalats: un canvi de paradigma de l'exposició sistèmica a l'exposició pulmonar https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/animal-models-for-womens-health-17295463775462400.html Prisys Biotech: models animals per a la terapèutica de la salut de la dona https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295464285611008.html Dia del Mundial de l'Obesitat|Models metabòlics de NHP de Prisys Biotech: alimentant el desenvolupament de teràpies anti-obesitat de nova generació https://ca.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://ca.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295464115381248.html Model de psoriasi de mico de Cynomolgus de Prisys Biotech: Avançament de la farmacodinàmica preclínica Avaluació https://ca.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://ca.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295463865459712.html Integració de farmacocinètica i farmacodinàmica en el desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://ca.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888513036493824.html Seminari web a-demanada|El pont de precisió: models CED guiats per ressonància magnètica-i NHP traduïbles per al lliurament de fàrmacs del SNC https://ca.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://ca.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295464235623424.html Què valida realment la prova de concepte (PoC) en el desenvolupament de fàrmacs? https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295463753229312.html Models animals|Reptes i aplicacions en el desenvolupament del model de dolor https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295464272192512.html Investigació farmacodinàmica no clínica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243637063148544.html Selecció del primat ideal no-humà per a estudis de toxicologia: macac Cynomolgus, macac Rhesus i tití https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120752.html Teràpia dirigida per a la malaltia de Parkinson: avenç en el trasplantament guiat de cèl·lules mare-MRI-en temps real https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295463919887360.html Lupus eritematós sistèmic (LES) i el paper dels models animals en el desenvolupament terapèutic https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295498806928384.html Model primat no humà per a l'artritis reumatoide (RA) https://ca.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://ca.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295463808902144.html Instruments estereotàctics del cervell animal basats en sistemes de coordenades 3D https://ca.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://ca.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295464097850368.html Models animals per a proves in vivo (1): establiment i classificació https://img01.v15cdn.com/gallery/4x3/148.webp https://ca.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83993440.html Explorant les rutes potencials perquè els biològics entrin al cervell https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83993457.html Avançar la investigació sobre l'artritis reumatoide (AR) amb models de primats no humans https://ca.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://ca.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83993460.html Explorant models animals per a l'eficàcia dels fàrmacs per a la dermatitis atòpica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83993985.html El paper crític dels models animals en la investigació de malalties humanes https://ca.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://ca.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83993441.html El model de mico de deficiència gènica de Parkin revela nous mecanismes i objectius terapèutics per a la malaltia de Parkinson https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83993461.html Guia de desenvolupament de fàrmacs no clínics: estudis de toxicitat general aguda, subaguda, subcrònica i crònica https://ca.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://ca.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83993451.html Entrega innovadora de fàrmacs nasal a cervell (N2B): obviant la barrera hematoencefàlica https://ca.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://ca.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83993450.html Oportunitats i reptes dels porcs mini com a espècie animal gran no clínica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83101651.html Estratègies de lliurament de medicaments per a malalties cerebrals https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83102707.html Navegació per ressonància magnètica intraoperatòria-en temps real: suport a l'aprovació de la FDA de la primera teràpia gènica per a la deficiència d'AADC https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83101643.html Estudis de toxicitat ocular de gotes per als ulls: exposició a fàrmacs i avaluació de seguretat https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82767574.html Prisys Biotech estableix el model de psoriasi del mico Cynomolgus per accelerar el desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82767575.html Models integrals de primats no-humans per a la investigació de malalties renals de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82767570.html Avaluació preclínica integral de seguretat dels conjugats de fàrmacs-anticossos (ADC) en primats no-humans https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82767573.html Avaluació farmacocinètica dels conjugats de fàrmacs-anticossos (ADC) en primats no-humans https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82767576.html Avaluació farmacodinàmica dels ADC https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82767581.html Comprendre el DMPK dels fàrmacs ADC https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82767577.html Avenços en el desenvolupament de fàrmacs d'àcid nucleic i capacitats de recerca de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82322110.html Avenços en sistemes de lliurament pulmonar d'ARNm i serveis innovadors de Prisys biotech https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82767591.html Per què es va concedir el Premi Nobel de Fisiologia o Medicina 2024 a aquests dos científics que van estudiar MicroRNA? https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82767584.html Consideracions farmacocinètiques (PK) per als fàrmacs del sistema nerviós central (SNC). https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656473.html Avenços en la investigació del SNC: el sistema d'injecció cerebral compatible amb la ressonància magnètica-de Prisys Biotech i la tecnologia CED https://ca.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://ca.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120289.html Avançar les innovacions terapèutiques de sagnat i coagulació amb el model MCAO de Cynomolgus Monkey https://ca.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://ca.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120286.html Avaluació DMPK de fàrmacs del sistema nerviós central (SNC). https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/animal-models-of-human-diseases-81120751.html Models animals de malalties humanes https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120290.html Innovacions en l'avaluació del dolor: anàlisi del comportament impulsada per l'IA- https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/china-experimental-monkey-industry-81120292.html Història, estat actual, reptes i oportunitats de la indústria experimental dels micos de la Xina https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/human-disease-animal-models-81120287.html Models animals de malalties humanes: una eina crucial per avançar en la investigació biomèdica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120288.html La importància de la farmacodinàmica preclínica en el desenvolupament de fàrmacs|Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://ca.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120282.html Administració intranasal en estudis d'animals https://ca.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://ca.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410521.html Revolucionant el desenvolupament de fàrmacs per al SNC: PRISYS Biotech presenta la tecnologia IMRI https://ca.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://ca.prisysbiotech.com/news/convection-enhanced-delivery-81120285.html Avançar la medicina de precisió: tecnologia de convecció-Enhanced Delivery (CED) de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://ca.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120284.html Model de malaltia renal crònica (ERC) del mico Cynomolgus de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://ca.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79526612.html Avaluació de seguretat no clínica del lliurament de fàrmacs oculars utilitzant macacos Cynomolgus https://ca.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://ca.prisysbiotech.com/news/compartment-pk-model-81120293.html Entendre els models compartimentals i no{0}}compartimentaris en farmacocinètica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120281.html Tècniques avançades de lliurament del SNC en micos Cynomolgus: acceleració del desenvolupament de fàrmacs oligonucleòtids https://ca.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://ca.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79526648.html Reducció de l'ús de primats no humans en avaluacions de seguretat no clíniques: perspectives de la FDA i la indústria https://ca.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://ca.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79526645.html Bioanàlisi preclínica LCMS de fàrmacs de teràpia gènica basats en LNP- https://ca.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://ca.prisysbiotech.com/news/mrna-based-therapies-past-79526641.html Teràpies basades en MRNA-: passat https://ca.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://ca.prisysbiotech.com/news/pk-strategies-of-pdc-79526605.html Estratègies d'estudi farmacocinètic dels conjugats de fàrmacs-pèptids (PDC) https://ca.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://ca.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79526616.html El paper de l'AAV en la teràpia gènica: respostes immunitàries i toxicitat https://ca.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://ca.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79527700.html Estratègies optimitzades d'avaluació de la immunogenicitat no clínica https://ca.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://ca.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79526642.html Avaluació farmacodinàmica (PD) de la teràpia gènica https://ca.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://ca.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79526629.html Farmacocinètica i bioanàlisi de fàrmacs oligonucleòtids-(1) https://ca.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://ca.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79526647.html Farmacocinètica i bioanàlisi de fàrmacs oligonucleòtids: característiques d'absorció i farmacocinètica plasmàtica (PK) https://ca.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://ca.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79526638.html Factors a considerar per a la immunogenicitat dels fàrmacs oligonucleòtids https://ca.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://ca.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79526650.html MRNA: una eina potent i versàtil per lluitar contra les malalties-Prisys-Biotech https://ca.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://ca.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79526628.html Científics xinesos ofereixen noves estratègies per revertir els símptomes bàsics de la malaltia de Parkinson https://ca.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://ca.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79526621.html Biotecnologia Prisys: nanopartícules de lípids noves per al lliurament de MRNA en primats https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79526626.html La importància de la investigació en medicina translacional des de la investigació bàsica fins als estudis clínics https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79526627.html Els principals factors considerats en l'anàlisi WOE https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79526625.html Com lliurar productes biològics al cervell? https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79526619.html Com es mouen i canvien els fàrmacs als nostres cossos: una breu introducció a la farmacocinètica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79526633.html Com desenvolupar nous fàrmacs més ràpid i més segur: una guia per als estudis preclínics de DMPK https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79526632.html Directrius d'allotjament en grup per a micos de laboratori https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79526624.html El paper vital dels micos experimentals en l'avanç de la investigació científica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79526640.html Comprendre Macaca Fascicularis (mono Cynomolgus): característiques clau i contribucions a la investigació biomèdica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79526618.html Revolucionant el tractament de malalties metabòliques: avenços i reptes en el desenvolupament de fàrmacs pèptids https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79526610.html Com avaluar la seguretat dels productes per a la pell abans dels assaigs clínics? https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79526646.html El paper significatiu dels micos experimentals en el desenvolupament de drogues innovadores: una mirada interior al negoci https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79526637.html La toxicitat hepàtica com a preocupació clau per als fàrmacs SiRNA: una anàlisi exhaustiva Especificitat de l'objectiu: l'espasa de doble-tall de SiRNA https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79526609.html Avançant en la terapèutica SiRNA: superant els reptes en el desenvolupament de fàrmacs https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79526606.html Perspectives d'aplicació de fàrmacs genètics basats en nanopartícules lipídiques https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79526631.html Punts clau en el disseny d'estratègies per a estudis no-clínics sobre animals juvenils https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79526623.html Informació sobre els trets sensorials i de comportament dels primats no-humans (NHP) https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79526639.html Q&A d'avaluació d'estudis no clínics https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/significance-principles-and-requirements-of-79526653.html Importància, principis i requisits de la investigació en farmacologia de seguretat https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79526620.html Com avaluar l'eficàcia farmacològica preclínica? https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79526611.html Reflexions sobre estudis de farmacologia no clínica i avaluació de fàrmacs terapèutics per a l'esteatohepatitis no alcohòlica (NASH) https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79526613.html Avançar en la investigació CNS i CGT: Prisys Biotechnologies https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79527697.html Directrius de recollida de líquid cefaloraquidi no-de primats humans https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79526614.html Consideracions per a la interpretació de dades de patologia clínica en primats no-humans (NHP) i canins https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79526604.html ​​​​​​​Integració de l'avaluació de seguretat del SNC en estudis de toxicologia general https://ca.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://ca.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79526634.html Com realitzar una avaluació preclínica de farmacologia/toxicologia dels ADC? https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526608.html ADME Insights per a fàrmacs oligonucleòtids (1) - Absorció, distribució https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526615.html ADME Insights per a fàrmacs oligonucleòtids (2) - Metabolisme i excreció https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79526596.html Estudis preclínics en animals (1) - Espècies animals https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79526603.html Reptes i estratègies d'interpretació de dades de patologia clínica en estudis preclínics de canins i primats no-humans https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79526643.html Estudis preclínics en animals (2) - Vies i volums d'administració https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/mrna-based-therapies-present-79526644.html Teràpies basades en MRNA-: present https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79526649.html Teràpies basades en MRNA-: futur i reptes https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79526636.html Breu introducció sobre l'anàlisi biològica de la teràpia gènica https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410522.html Mico Cynomolgus a la investigació de fàrmacs oftàlmics https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410523.html Estudis translacionals i-reactius creuats amb els models NHP d'immunologia i inflamació de Prisys https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79185523.html PSN no-naïfs en assaigs preclínics: una solució rendible-de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/nhp-asthma-model-79185524.html Model d'asma NHP: potenciació dels estudis preclínics d'eficàcia dels fàrmacs amb Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79185522.html Avançar la investigació en immunologia i inflamació amb models de macacos de Cynomolgus - Prisys Biotechnologies https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79185520.html Lliurament directe de fàrmacs oligonucleòtids al SNC i canvis histopatològics comuns https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79186859.html Model intra-d'ictus cerebral (ICH) de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75180875.html Recerca en farmacodinàmica no-clínica: un aspecte essencial en el desenvolupament de fàrmacs SiRNA https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-78082048.html El sistema de localització i lliurament de precisió del sistema nerviós central guiat per ressonància magnètica-s'instal·la a Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://ca.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77130738.html Solucions innovadores per avançar en la terapèutica respiratòria https://ca.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://ca.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74825638.html Prisys: avançar en l'experimentació amb animals mitjançant estudis de macacs Cynomolgus https://ca.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://ca.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76271360.html Prisys aconsegueix l'acreditació total d'AAALAC International: una fita per garantir uns alts estàndards de cura dels animals de laboratori. https://ca.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://ca.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74715452.html Augment de la terapèutica d'àcids nucleics a través de{0}}avantguarda amb models de primats no humans de Prisys Biotech https://ca.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://ca.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74231533.html Revolucionant el lliurament de fàrmacs al SNC: Prisys i la promesa de la injecció intratecal https://img01.v15cdn.com/gallery/4x3/148.webp https://ca.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75180874.html Butlletí informatiu Prisys Biotech 2024 Q1 - el vostre especialista en estudis de primats no humans fiable https://ca.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://ca.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73857893.html Com la-biòpsia hepàtica guiada per ultrasons millora la investigació basada en macac- https://ca.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://ca.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73857252.html Directrius per a l'ús de tota la vida de primats no humans en investigació biomèdica: una perspectiva de biotecnologia de Prisys https://ca.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://ca.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73037396.html Primats no-humans: una breu introducció a les seves característiques biològiques https://ca.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://ca.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72719586.html Ressenya de l'exposició|Prisys Biotech brilla a la reunió anual de la Societat Americana de Neurociència (SfN 2023) https://ca.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://ca.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72338644.html Coneix Prisys Biotech a la reunió anual de la Society for Neuroscience (SfN 2023) https://ca.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://ca.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72338645.html Dia Mundial de l'Ictus|Centrar-se en models animals i farmacologia d'ictus isquèmic https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72338640.html Prisys Biotech us convida a assistir a la reunió anual SAPA-Xina el 2023 https://ca.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://ca.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72338641.html Dia Mundial de l'Alzheimer|Els reptes i solucions per al desenvolupament de fàrmacs AD https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72338643.html El model animal Cynomolgus Macaque de Prisys Biotech ajuda al desenvolupament de nous fàrmacs anticoagulants https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71033930.html Prisys: proporciona un servei d'experimentació animal d'alta qualitat per al nou anticòs BJTJ-1837 del factor XI de la coagulació anti- https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71034076.html Mètode per establir un model de mico Cynomolgus d'hipertrigliceridèmia i la seva aplicació https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71033975.html Farmacologia: paràmetres principals i importància de la farmacocinètica (PK) https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71033873.html Avaluació farmacològica preclínica de fàrmacs oncolítics https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/0-71033971.html Com els petits fàrmacs d'àcid nucleic poden transformar el tractament de les malalties del SNC: informació de Prisys Biotechnology, un proveïdor de models de malalties NHP https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71034029.html Farmacocinètica, estratègies de recerca i estudis de cas de fàrmacs pèptids https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69671735.html Punts clau d'investigació d'ADC Drug PK https://img01.v15cdn.com/gallery/4x3/148.webp https://ca.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69671733.html Prisys Biotechnology: un líder en la plataforma de recerca de modelització de malalties del SNC de NHP https://ca.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://ca.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309307.html Com perdre pes i controlar la diabetis amb productes GLP-1 https://ca.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://ca.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309306.html Com la Xina Monkey ajuda a dur a terme una investigació preclínica eficient? https://ca.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://ca.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309387.html Quina és l'eficiència de l'RNAi? https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309266.html Plataforma de servei públic d'experimentació amb animals grans de Prisys Biotech: solució de baix-cost i alta-eficiència per a experiments amb grans animals https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69060503.html Com la teràpia gènica AAV pot salvar la vostra visió: els darrers avenços dels estudis sobre primats no-humans https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69065722.html Prisys Biotech presenta una plataforma de models de primats no-humans a la reunió anual de la Societat Japonesa de Toxicologia https://ca.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://ca.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69079908.html El futur prometedor de la teràpia gènica AAV en primats no-humans https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69073358.html Què són les nanopartícules lipídiques per a la teràpia gènica? https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69072054.html Prisys Biotech us convida a participar a la 50a reunió anual de la Societat Japonesa de Toxicologia (JSOT) https://ca.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://ca.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69075680.html Prova d'immunotoxicitat, avaluació de la seguretat dels medicaments-PRISYS BIOTECH https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68338298.html Un model animal òptim d'ictus isquèmic establert per angiografia de substracció digital-Trombis autòlegs guiats en micos Cynomolgus https://ca.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://ca.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68135788.html Per què us hauríeu de preocupar pels primats no-humans a la investigació i desenvolupament del sistema d'admissió de fàrmacs d'àcid nucleic https://ca.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ca.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68135790.html Coneix Prisys Biotech al 70è JALAS 2023! https://ca.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://ca.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68135789.html La teràpia gènica brilla amb noves aprovacions per a malalties rares https://ca.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://ca.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68135787.html Revolucionant el descobriment de fàrmacs: com els primats no humans optimitzen el cribratge de SiRNA per obtenir resultats més ràpids i eficients https://ca.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://ca.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67576831.html Maximització de l'eficiència de la farmacologia SiRNA amb la investigació de primats no humans https://ca.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://ca.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67577694.html Com els primats no humans poden revolucionar la investigació de SiRNA: una guia completa https://ca.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://ca.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67579579.html Celebrant el Dia Mundial dels Animals de Laboratori: Per què Prisys es compromet a promoure la salut dels primats no humans https://ca.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://ca.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67598057.html Maximització de l'eficiència de la investigació CRISPR/Cas9 amb models de primats no humans https://ca.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://ca.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67578421.html Alliberar el potencial terapèutic: per què invertir en fàrmacs d'àcid nucleic és el futur de la medicina https://ca.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://ca.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67576830.html Desbloquejar el potencial dels primats no humans per millorar el descobriment d'objectius de fàrmacs de teràpia gènica https://ca.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://ca.prisysbiotech.com/news/world-parkinsons-disease-day-67581566.html Unite For Parkinson: unint les mans per conscienciar sobre el Dia Mundial de la Malaltia de Parkinson https://ca.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://ca.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67587952.html Com utilitzar els primats no-humans amb eficàcia en l'avaluació de la seguretat de la teràpia gènica https://ca.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://ca.prisysbiotech.com/news/gene-therapy-toxicology-66279703.html Recerca en toxicologia de teràpia gènica amb primats de Nonhuam https://ca.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://ca.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66148668.html Una guia completa per dur a terme un estudi DMPK per a la teràpia gènica https://ca.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://ca.prisysbiotech.com/news/gene-therapy-nhp-model-66148664.html Revolucionant la investigació mèdica: avenços en teràpia gènica en models de malaltia de primats no humans! https://ca.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://ca.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66148667.html Les 10 preguntes més populars relacionades amb la teràpia gènica https://ca.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://ca.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66148666.html Prisys Biotech: Farmacologia de primats no-humans per a la teràpia gènica https://ca.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://ca.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66148665.html Donar suport a la salut de la dona: una mirada a l'endometriosi https://ca.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://ca.prisysbiotech.com/news/prisys-sot2023-66148660.html PRISYS i Taichu Group col·laboren per a l'exposició SOT el 2023 https://ca.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://ca.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66148661.html Necessitem més estudis per a l'avaluació del dolor? - NHP https://ca.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://ca.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66148662.html Uneix-te a nosaltres per celebrar el Dia Mundial de la Vida Silvestre https://ca.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://ca.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66148663.html Llançament del Centre d'R+D de Prisys Shanghai NHP, marcant una fita en la investigació i desenvolupament farmacèutic a la Xina https://ca.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://ca.prisysbiotech.com/news/meetprisys-sot2023-66148659.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://ca.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg